Trend-Following Hedge Funds Make a Positive Start to January (Hedge Week)
Managed futures hedge funds have made a positive early start to the year, following a tough 12 months in which volatility spikes and see-saw performances in many assets made it tricky for computer-based strategies to capitalise on market trends. Two out of the three daily CTA indices produced by Société Générale were in the black entering the final week of January. The main SocGen CTA Index, which measures the daily performance of a select pool of 20 of the largest managed futures strategies, has advanced 1.43 per cent since the start of 2021.
Coller Capital Amasses $9bn for the Latest Secondaries Fund (Opalesque.com)
UK-based Coller Capital has raised more than $9 billion for its latest fund that will buy and sell investors’ stakes in private-equity funds. According to a press release from the global investors in the private equity secondary market, the Coller International Partners VIII fund (CIP VIII) makes individual investments of up to $1 billion or more in global secondary transactions. “Advised by a multinational team based in London, New York, and Hong Kong, the fund will target a wide array of secondary transactions, targeting assets and sellers located anywhere in the world,” said the release.
Monday 1/25 Insider Buying Report: TSRI, PSXP (Nasdaq.com)
At TSRI, a filing with the SEC revealed that on Friday, Director Bradley M. Tirpak purchased 7,758 shares of TSRI, for a cost of $6.41 each, for a total investment of $49,758. Tirpak was up about 14.1% on the purchase at the high point of today’s trading session, with TSRI trading as high as $7.32 at last check today. TSR Inc is trading up about 3% on the day Monday. This purchase marks the first one filed by Tirpak in the past year. And on Wednesday, Director Phillip David Bairrington purchased $43,437 worth of Phillips 66 Partners, purchasing 1,445 shares at a cost of $30.06 a piece. Before this latest buy, Bairrington purchased PSXP at 2 other times during the past twelve months, for a total investment of $813,036 at an average of $27.10 per share. Phillips 66 Partners is trading up about 0.7% on the day Monday. Bargain hunters have the opportunity to pick up PSXP even cheaper than Bairrington did, with shares trading as low as $28.56 in trading on Monday — that’s 5.0% under Bairrington’s purchase price.
Zoom Video Communications Inc (ZM) CEO Eric S. Yuan Sold $53.3 million of Shares (Guru Focus)
CEO of Zoom Video Communications Inc, Eric S. Yuan, sold 140,284 shares of ZM on 01/21/2021 at an average price of $379.71 a share. The total sale was $53.3 million. Zoom Video Communications Inc has a market cap of $111.91 billion; its shares were traded at around $383.400000 with a P/E ratio of 268.11 and P/S ratio of 58.22.
The Lead Independent Director of CI Financial (NYSE: CIFAF) is Buying Shares (Analyst Ratings)
Today, the Lead Independent Director of CI Financial (CIFAF), Thomas Pinaud Muir, bought shares of CIFAF for $248K. This recent transaction increases Thomas Pinaud Muir’s holding in the company by 23% to a total of $1.04 million. In addition to Thomas Pinaud Muir, 4 other CIFAF executives reported Buy trades in the last month.
Notable Insider Buys Of The Past Week: Affirm, HEICO, Vector Group, Biotechs And More (Benzinga)
Here are some of the most noteworthy insider purchases that were reported in the past week. Biotech company Aldeyra Therapeutics Inc (NASDAQ: ALDX) saw a 10% owner return and add almost 1.37 million shares to its stake. At a secondary offering price of $9.50 per share, the transaction totaled about $13 million. The stock closed most recently at $12.29 a share, after hitting a 52-week high of $14.62 earlier in the week. It is up about 79% year to date. Cancer-testing products maker OncoCyte Corp (AMEX: OCX) also had a 10% owner increase its stake last week. The more than 1.46 million shares acquired, at an offering price of about $3.42, added up to approximately $5 million. That raised that owner’s stake to more than 16.17 million shares, compared to a total float of more than 57 million. The stock closed most recently at $4.76 per share, which is more than 39% higher than the purchase price.
